Queen Mary University Of London
Clinical trials sponsored by Queen Mary University Of London, explained in plain language.
-
New hope for malnourished kids: trial tests dual attack on infections and caregiver stress
Disease control OngoingThis study aims to improve recovery for young children who have been hospitalized with severe, complicated malnutrition. It is testing two different support packages against standard care: one provides extended antibiotics to prevent infections, and the other offers psychological…
Phase: PHASE3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
New hope for hepatitis c patients whose first treatment failed
Disease control ENROLLING_BY_INVITATIONThis study aims to find the best second treatment for people in Pakistan whose Hepatitis C infection did not clear after their first round of antiviral drugs. It will compare two different lengths of a follow-up drug combination (12 weeks vs. 24 weeks) in about 318 adults. The go…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Old drug, new hope: repurposing ATRA to fight tough pancreatic tumors
Disease control OngoingThis trial is testing whether adding an existing drug called ATRA to standard chemotherapy helps control locally advanced pancreatic cancer better. About 170 patients will receive either the standard two-drug combo or the standard combo plus ATRA. Researchers will measure if the …
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for halting MS disability: drug trial aims to save crucial arm function
Disease control OngoingThis UK trial is testing whether a drug called cladribine can slow the loss of arm and hand function in people with advanced multiple sclerosis (MS). Over two years, about 200 participants will receive either the drug or a placebo to see which better protects their ability to per…
Phase: PHASE2, PHASE3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Breakthrough test could revolutionize TB screening
Diagnosis ENROLLING_BY_INVITATIONThis study is evaluating a new blood test designed to detect the bacteria that cause dormant tuberculosis (TB) infection. Current tests can't tell if someone has been cured after treatment or identify which infected people will actually get sick. Researchers will test 250 people,…
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Mar 25, 2026 14:09 UTC
-
Stick-On sensor could replace painful blood tests after heart surgery
Diagnosis OngoingThis study is testing a new, painless skin sensor that measures a substance called lactate, which can indicate how well the body is recovering after major heart surgery. Researchers want to see if the sensor's readings are as accurate as the standard method, which requires freque…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Mar 20, 2026 14:47 UTC
-
New test could cut days off dangerous heart infection diagnosis
Diagnosis OngoingThis study is testing a new blood test that reads bacterial DNA to quickly identify the specific germ causing a serious heart valve infection called infective endocarditis. The goal is to see if this new test is as accurate as the current standard method, which can take up to fiv…
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Mar 17, 2026 13:09 UTC
-
Could a bacterial pill stop babies from wheezing?
Prevention OngoingThis study is testing if a capsule containing bacterial proteins (Broncho-Vaxom) can prevent wheezing in infants who were hospitalized with a severe lung infection called bronchiolitis. Researchers are enrolling 173 infants and giving them either the bacterial supplement or a pla…
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Prevention
Last updated Mar 30, 2026 14:35 UTC
-
Scientists dig through old records to predict prostate cancer fate
Knowledge-focused OngoingThis study analyzed medical records and tissue samples from over 3,300 men diagnosed with early-stage prostate cancer between 1990 and 2006 who chose watchful waiting (no immediate treatment). Researchers looked back at these cases to identify which factors—like PSA levels, cance…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
New study offers At-Home HPV tests to improve screening for transgender community
Knowledge-focused OngoingThis study is exploring if self-collected samples (like vaginal swabs, urine, and mouthwash) are a good and acceptable way to check for high-risk HPV in transgender people. It aims to understand how common HPV is in this community and if self-testing could make cancer screening m…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:52 UTC